ESR1 and breast carcinoma: In this regards, this aspect needs to be taken into consideration when TAM is used to treat patients with ER+-breast cancer, though TAM's anti-HCV activity was found to abrogate the functional association of ER with viral RNA polymerase NS5B [75].